Cygnus GlucoWatch Pilot Marketing Program To Begin In April
This article was originally published in The Gray Sheet
Executive Summary
Cygnus plans to kick off a pilot marketing program in April targeting 100-150 Type 1 diabetes patients to gauge firsthand consumer experience with the GlucoWatch Biographer. The non-invasive glucose monitoring system was approved by FDA on March 22.
You may also be interested in...
Cygnus GlucoWatch Biographer Non-Invasive Glucose Monitor Lists For $595
Cygnus' full-scale U.S. launch of the GlucoWatch Biographer non-invasive glucose monitoring system April 15 includes a direct mail list price of $595
Cygnus GlucoWatch Biographer Non-Invasive Glucose Monitor Lists For $595
Cygnus' full-scale U.S. launch of the GlucoWatch Biographer non-invasive glucose monitoring system April 15 includes a direct mail list price of $595
Cygnus GlucoWatch
Non-invasive glucose monitoring system indication for use by diabetics ages 7-17 is sought in a PMA supplement submission, announced Sept. 24. The device was approved for adults 18 and older on March 22 (1"The Gray Sheet" March 26, 2001, p. 13). About 100,000 children and 16 mil. adults have diabetes in the U.S. While the wristwatch-like device is currently available under a pilot marketing program, Cygnus is preparing for a full-scale launch and reports to be "in advanced discussions with multiple companies for a potential sales alliance in the U.S."